320 GENES FOUND
Show / hide columns »
XML |
RDF |
TAB |
« prev | Page next »
GJA3 Gap junction protein, alpha 3, 46kDa Disease related genes Tissue enhanced
GJA4 Gap junction protein, alpha 4, 37kDa Predicted membrane proteins Tissue enhanced
GJB1 Gap junction protein, beta 1, 32kDa Disease related genes Tissue enhanced
GJB2 Gap junction protein, beta 2, 26kDa Disease related genes Mitochondria Tissue enriched
GJC1 Gap junction protein, gamma 1, 45kDa Predicted intracellular proteins Nucleoli Tissue enhanced
GJC3 Gap junction protein, gamma 3, 30.2kDa Predicted membrane proteins Tissue enhanced
GJD4 Gap junction protein, delta 4, 40.1kDa Predicted membrane proteins Mixed
GLE1 GLE1 RNA export mediator Disease related genes Nuclear membrane Expressed in all
GLRA1 Glycine receptor, alpha 1 Disease related genes Not detected
GLRA2 Glycine receptor, alpha 2 FDA approved drug targets Group enriched
GLRB Glycine receptor, beta Disease related genes Tissue enhanced
GNLY Granulysin Predicted intracellular proteins Tissue enhanced
GRIA2 Glutamate receptor, ionotropic, AMPA 2 Predicted intracellular proteins Tissue enriched
GRIA3 Glutamate receptor, ionotropic, AMPA 3 Disease related genes Tissue enhanced
GRIN1 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 Disease related genes Tissue enriched
HSPA1A Heat shock 70kDa protein 1A Cancer-related genes Nucleoplasm Mixed
HSPA1B Heat shock 70kDa protein 1B Cancer-related genes Nucleoplasm Tissue enhanced
HTN3 Histatin 3 Predicted secreted proteins Vesicles Tissue enriched
HVCN1 Hydrogen voltage gated channel 1 Predicted intracellular proteins Mixed
IPO11 Importin 11 Plasma proteins Nucleus Expressed in all
IPO13 Importin 13 Predicted intracellular proteins Expressed in all
IPO4 Importin 4 Predicted intracellular proteins Cytosol Tissue enhanced
IPO5 Importin 5 Plasma proteins Nucleoplasm Expressed in all
IPO7 Importin 7 Cancer-related genes Nucleoplasm Expressed in all
IPO8 Importin 8 Predicted intracellular proteins Nucleus Expressed in all
IPO9 Importin 9 Predicted intracellular proteins Vesicles Expressed in all
ITPR1 Inositol 1,4,5-trisphosphate receptor, type 1 Disease related genes Vesicles Tissue enhanced
KCNA2 Potassium channel, voltage gated shaker related subfamily A, member 2 Disease related genes Tissue enriched
KCNA3 Potassium channel, voltage gated shaker related subfamily A, member 3 FDA approved drug targets Mixed
KCNA5 Potassium channel, voltage gated shaker related subfamily A, member 5 Disease related genes Tissue enhanced
KCNB1 Potassium channel, voltage gated Shab related subfamily B, member 1 Disease related genes Tissue enhanced
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes Tissue enhanced
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes Mixed
KCNF1 Potassium channel, voltage gated modifier subfamily F, member 1 Plasma proteins Golgi apparatus Tissue enriched
KCNH1 Potassium channel, voltage gated eag related subfamily H, member 1 Disease related genes Vesicles Tissue enriched
KCNH3 Potassium channel, voltage gated eag related subfamily H, member 3 Predicted membrane proteins Nucleus Group enriched
KCNJ1 Potassium channel, inwardly rectifying subfamily J, member 1 Disease related genes Tissue enriched
KCNJ16 Potassium channel, inwardly rectifying subfamily J, member 16 Predicted intracellular proteins Vesicles Group enriched
KCNJ2 Potassium channel, inwardly rectifying subfamily J, member 2 Disease related genes Tissue enhanced
KCNJ3 Potassium channel, inwardly rectifying subfamily J, member 3 Plasma proteins Tissue enhanced
KCNJ5 Potassium channel, inwardly rectifying subfamily J, member 5 Cancer-related genes Tissue enhanced
KCNJ8 Potassium channel, inwardly rectifying subfamily J, member 8 Disease related genes Mixed
KCNK15 Potassium channel, two pore domain subfamily K, member 15 Predicted membrane proteins Tissue enhanced
KCNK17 Potassium channel, two pore domain subfamily K, member 17 Predicted membrane proteins Tissue enhanced
KCNK5 Potassium channel, two pore domain subfamily K, member 5 Predicted membrane proteins Nucleus Tissue enhanced
KCNK6 Potassium channel, two pore domain subfamily K, member 6 Predicted membrane proteins Plasma membrane Mixed
KCNN2 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 Plasma proteins Nucleoplasm Tissue enhanced
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes Tissue enhanced
« prev | Page next »
